Literature DB >> 8139570

Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.

J Y Kato1, M Matsuoka, D K Strom, C J Sherr.   

Abstract

The accumulation of assembled holoenzymes composed of regulatory D-type cyclins and their catalytic partner, cyclin-dependent kinase 4 (cdk4), is rate limiting for progression through the G1 phase of the cell cycle in mammalian fibroblasts. Both the synthesis and assembly of D-type cyclins and cdk4 depend upon serum stimulation, but even when both subunits are ectopically overproduced, they do not assemble into complexes in serum-deprived cells. When coexpressed from baculoviral vectors in intact Sf9 insect cells, cdk4 assembles with D-type cyclins to form active protein kinases. In contrast, recombinant D-type cyclin and cdk4 subunits produced in insect cells or in bacteria do not assemble as efficiently into functional holoenzymes when combined in vitro but can be activated in the presence of lysates obtained from proliferating mammalian cells. Assembly of cyclin D-cdk4 complexes in coinfected Sf9 cells facilitates phosphorylation of cdk4 on threonine 172 by a cdk-activating kinase (CAK). Assembly can proceed in the absence of this modification, but cdk4 mutants which cannot be phosphorylated by CAK remain catalytically inactive. Therefore, formation of the cyclin D-cdk4 complex and phosphorylation of the bound catalytic subunit are independently regulated, and in addition to the requirement for CAK activity, serum stimulation is required to promote assembly of the complexes in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139570      PMCID: PMC358637          DOI: 10.1128/mcb.14.4.2713-2721.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Role of phosphorylation in p34cdc2 activation: identification of an activating kinase.

Authors:  M J Solomon; T Lee; M W Kirschner
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

2.  Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies.

Authors:  A Hoffmann; R G Roeder
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

3.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

4.  Cloning of a D-type cyclin from murine erythroleukemia cells.

Authors:  H Kiyokawa; X Busquets; C T Powell; L Ngo; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

5.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Authors:  H Matsushime; M F Roussel; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

6.  Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Authors:  M Meyerson; E Harlow
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

7.  Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites.

Authors:  W Krek; E A Nigg
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

8.  cdc2 phosphorylation is required for its interaction with cyclin.

Authors:  B Ducommun; P Brambilla; M A Félix; B R Franza; E Karsenti; G Draetta
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

9.  Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates.

Authors:  C Norbury; J Blow; P Nurse
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

10.  Phosphorylation at Thr167 is required for Schizosaccharomyces pombe p34cdc2 function.

Authors:  K L Gould; S Moreno; D J Owen; S Sazer; P Nurse
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  94 in total

1.  Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4.

Authors:  J M Zhang; Q Wei; X Zhao; B M Paterson
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  CAK-independent activation of CDK6 by a viral cyclin.

Authors:  P Kaldis; P M Ojala; L Tong; T P Mäkelä; M J Solomon
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

Review 3.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer.

Authors:  Wenfeng Yang; Yongming Zhang; Zheng Fu; Jinming Yu; Xiaorong Sun; Dianbin Mu; Anqin Han
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-23       Impact factor: 9.236

5.  Structure of an Hsp90-Cdc37-Cdk4 complex.

Authors:  Cara K Vaughan; Ulrich Gohlke; Frank Sobott; Valerie M Good; Maruf M U Ali; Chrisostomos Prodromou; Carol V Robinson; Helen R Saibil; Laurence H Pearl
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

6.  Recombinant Leishmania mexicana CRK3:CYCA has protein kinase activity in the absence of phosphorylation on the T-loop residue Thr178.

Authors:  Felipe C Gomes; Nahla Osman M Ali; Elaine Brown; Roderick G Walker; Karen M Grant; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-03-23       Impact factor: 1.759

7.  Crystal structure of human CDK4 in complex with a D-type cyclin.

Authors:  Philip J Day; Anne Cleasby; Ian J Tickle; Marc O'Reilly; Joe E Coyle; Finn P Holding; Rachel L McMenamin; Jeff Yon; Rajiv Chopra; Christoph Lengauer; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

9.  Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities.

Authors:  P Kaldis; A A Russo; H S Chou; N P Pavletich; M J Solomon
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

10.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.